• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肿瘤靶向生物功能的仿生药物传递系统

Biomimetic Drug Delivery Systems Oriented by Biological Function in Tumor Targeting.

机构信息

Key Laboratory of Smart Drug Delivery, Ministry of Education, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China.

出版信息

Curr Drug Targets. 2021;22(8):882-895. doi: 10.2174/1389450122666210114095859.

DOI:10.2174/1389450122666210114095859
PMID:33459231
Abstract

The emergence of nanoscale drug delivery systems provides new opportunities for targeting the delivery of chemotherapeutic drugs and has achieved excellent results. In recent years, with the rise in the concept of intelligent drug delivery systems, the design and preparation of carriers have become more and more complicated, which is not conducive to clinical transformation. Researchers are gradually focused on biomimetic nanoscale drug delivery systems, trying to combine the physicochemical properties of nanoscale carriers with the natural biological functions of endogenous substances, so as to boost tumor targeting delivery. In this article, we first classify and introduce biomimetic nanoscale drug delivery systems, and then emphasize their unique biological functions. The biomimetic nanoscale drug delivery systems have the advantages of simple preparation, powerful functions, and low immunogenicity, having a good application prospect.

摘要

纳米药物递送系统的出现为化疗药物的靶向递送提供了新的机会,并取得了优异的效果。近年来,随着智能药物递送系统概念的兴起,载体的设计和制备变得越来越复杂,不利于临床转化。研究人员逐渐关注仿生纳米药物递送系统,试图将纳米载体的物理化学性质与内源性物质的天然生物学功能相结合,以促进肿瘤靶向递药。本文首先对仿生纳米药物递送系统进行分类介绍,然后重点强调其独特的生物学功能。仿生纳米药物递送系统具有制备简单、功能强大、免疫原性低等优点,具有良好的应用前景。

相似文献

1
Biomimetic Drug Delivery Systems Oriented by Biological Function in Tumor Targeting.基于肿瘤靶向生物功能的仿生药物传递系统
Curr Drug Targets. 2021;22(8):882-895. doi: 10.2174/1389450122666210114095859.
2
Application of Biomimetic Nanoparticles based on the Cell Membrane in Tumor Therapy.基于细胞膜的仿生纳米粒子在肿瘤治疗中的应用。
Curr Top Med Chem. 2023;23(10):907-920. doi: 10.2174/1568026623666230427114622.
3
Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.混合细胞膜包覆纳米颗粒:用于癌症诊断与治疗的多功能仿生平台。
Acta Biomater. 2020 Aug;112:1-13. doi: 10.1016/j.actbio.2020.05.028. Epub 2020 May 26.
4
The potential of biomimetic nanoparticles for tumor-targeted drug delivery.仿生纳米粒子在肿瘤靶向药物传递中的潜力。
Nanomedicine (Lond). 2018 Aug;13(16):2099-2118. doi: 10.2217/nnm-2018-0017. Epub 2018 Sep 18.
5
Biomimetic nanoarchitecturing: A disguised attack on cancer cells.仿生纳米结构:对癌细胞的伪装攻击。
J Control Release. 2021 Jan 10;329:413-433. doi: 10.1016/j.jconrel.2020.12.005. Epub 2020 Dec 8.
6
Biomimetic nanoparticles for DC vaccination: a versatile approach to boost cancer immunotherapy.仿生纳米颗粒用于树突状细胞疫苗接种:一种增强癌症免疫治疗的多功能方法。
Nanoscale. 2023 Apr 6;15(14):6432-6455. doi: 10.1039/d2nr07071e.
7
Hybrid Membrane-Coated Biomimetic Nanoparticles (HM@BNPs): A Multifunctional Nanomaterial for Biomedical Applications.杂化膜包覆仿生纳米粒子 (HM@BNPs):一种用于生物医学应用的多功能纳米材料。
Biomacromolecules. 2021 Aug 9;22(8):3149-3167. doi: 10.1021/acs.biomac.1c00440. Epub 2021 Jul 6.
8
Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment.仿生纳米药物传递系统:促进肿瘤治疗的新兴平台。
Int J Nanomedicine. 2024 Jan 18;19:571-608. doi: 10.2147/IJN.S442877. eCollection 2024.
9
Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.仿生响应型纳米载体的构建及其在肿瘤靶向中的应用。
Anticancer Agents Med Chem. 2022;22(12):2255-2273. doi: 10.2174/1871520622666220106105315.
10
A Review of Biomimetic Nanoparticle Drug Delivery Systems Based on Cell Membranes.基于细胞膜的仿生纳米药物传递系统综述。
Drug Des Devel Ther. 2020 Dec 14;14:5495-5503. doi: 10.2147/DDDT.S282368. eCollection 2020.

引用本文的文献

1
Engineered biomimetic vesicles induce cuproptosis and disrupt efferocytosis for metastatic adenoid cystic carcinoma immunotherapy.工程化仿生囊泡诱导铜死亡并破坏吞噬作用以用于转移性腺样囊性癌免疫治疗。
Mater Today Bio. 2025 Aug 23;34:102233. doi: 10.1016/j.mtbio.2025.102233. eCollection 2025 Oct.
2
Recent Advances in Targeted Therapies for Infantile Hemangiomas.婴幼儿血管瘤靶向治疗的最新进展。
Int J Nanomedicine. 2024 Jun 19;19:6127-6143. doi: 10.2147/IJN.S463119. eCollection 2024.
3
Emerging non-antibody‒drug conjugates (non-ADCs) therapeutics of toxins for cancer treatment.
用于癌症治疗的新型毒素非抗体药物偶联物(非ADC)疗法。
Acta Pharm Sin B. 2024 Apr;14(4):1542-1559. doi: 10.1016/j.apsb.2023.11.029. Epub 2023 Nov 30.